Study: This protein may be the 'glue' that helps COVID virus stick
When SARS-CoV-2 enters the human body, the virus' spike protein binds to a cell, allowing the virus to infiltrate and begin replicating.
Jan 24, 2024
0
3
When SARS-CoV-2 enters the human body, the virus' spike protein binds to a cell, allowing the virus to infiltrate and begin replicating.
Jan 24, 2024
0
3
Since the beginning of the COVID-19 pandemic, Raghavan Varadarajan, Professor at the Molecular Biophysics Unit (MBU), Indian Institute of Science (IISc), and collaborators have been working on developing a heat-tolerant vaccine ...
Jan 11, 2024
0
35
Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked ...
Jan 9, 2024
0
119
For a third season, COVID-19 cases are rising ahead of the holidays, this time with a more recent variant driving infections.
Dec 23, 2023
1
0
When the COVID-19 pandemic first started, no effective anti-viral drugs were available to fight the disease. However, in record time, so-called monoclonal antibodies were developed as a lifesaving treatment. Now, three years ...
Nov 29, 2023
0
65
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced ...
Nov 6, 2023
0
72
When the first vaccines for COVID-19 rolled out in December 2020, some people hoped they would be a silver bullet against the novel virus the way that polio and smallpox shots are nearly 100% effective against those diseases.
Nov 3, 2023
0
23
A new study by a team of researchers at the University of Toronto's Emerging and Pandemic Infections Consortium (EPIC) has uncovered biological reasons underlying sex differences in COVID-19 outcomes, offering a promising ...
Oct 3, 2023
0
18
A synthetic peptide developed by researchers at the Medical College of Georgia could help reduce vascular problems associated with acute respiratory distress syndrome (ARDS) in COVID-19.
Oct 3, 2023
0
23
Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine's content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just ...